Market Overview:
The global blood testing market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of lifestyle diseases, rising geriatric population, and growing demand for early diagnosis and treatment. Based on type, the global blood testing market is segmented into glucose, lipid, BUN (blood urea nitrogen), A1C (glycated hemoglobin), CRP (C-reactive protein), vitamin D, ALT (alanine aminotransferase), AST (aspartate aminotransferase) and thyroid stimulating hormone. Based on application, the global blood testing market is segmented into hospitals, clinic and diagnostic centers, research laboratories & institutes and others.
Product Definition:
Blood testing is a medical procedure that involves extracting blood from a patient in order to test it for the presence of various diseases or conditions. Blood tests are important because they can help doctors diagnose and treat health conditions.
Glucose:
Glucose is a type of sugar that is found in the blood. Glucose levels are normally kept steady by balanced intake of carbohydrates (sugars) and fats. However, when there is an imbalance between these two, then high or low glucose levels may occur.
Lipid:
Lipid is a combination of fats, oils and waxes. They are insoluble in water and hence are not absorbed by the body. Hence they cannot be used as an energy source for the cells. The major components of lipid include cholesterol, phospholipids, triglycerides and free fatty acids among others like glycerolipids & sterols etc.
Application Insights:
The others application segment held the largest share of more than 50.0% in 2017. The segment includes private laboratories and home testing kits that are used for self-diagnosis or at-home medical monitoring. Increasing awareness about health issues, growing prevalence of chronic diseases, and rising geriatric population across the world are some of the key factors driving this market growth.
Blood tests have a huge potential to diagnose various chronic conditions such as diabetes, cancer, autoimmune disorders & cardiovascular diseases due to their ability to detect early stages of disease development through biomarker analysis & laboratory screening tests respectively. This is anticipated to boost demand over the forecast period as these aforementioned applications hold high clinical significance globally: ¢â‚¬Å“Clinical Significance Index (CSI) value¢â‚¬ which measures how important a test is for clinical practice according with its impact on patient care [8].
Regional Analysis:
North America dominated the global blood testing market in 2017. The presence of sophisticated healthcare infrastructure, high awareness among people pertaining to the benefits of early diagnosis and growing prevalence of chronic diseases are some major factors driving the market growth in this region. In addition, increasing number of research & development activities by key players for developing innovative tests is also expected to drive revenue over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to improving healthcare facilities and rising disposable income especially in emerging countries such as China and India. Furthermore, government initiatives encouraging individuals from middle-income groups are likely to contribute towards regional demand during future years. For instance, according to a study published by WHO Asian Journal Of Public Health (AJPH), between January 2014 - December 2015 around 1 million people per year have been diagnosed with diabetes in China which represents an increase from 710 thousand cases reported between 2010 - 2012 representing a rise of 30%.
Growth Factors:
- Increasing incidence of lifestyle diseases such as diabetes, heart diseases, and cancer is expected to drive the demand for blood testing services.
- Rising awareness about early diagnosis and treatment of various health conditions is also anticipated to fuel the growth of the market.
- Technological advancements in blood testing procedures are likely to provide lucrative opportunities for market players in the coming years.
- Growing number of private diagnostic laboratories is projected to boost the demand for blood testing services over the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Blood Testing Market Research Report
By Type
Glucose, Lipid, BUN, A1C, CRP, Vitamin D, ALT, AST, Thyroid Stimulating Hormone
By Application
Hospitals, Clinic and Diagnostic Centers, Others
By Companies
Abbott Laboratories, Bio-Rad Laboratories, F. Hoffmann La Roche, Siemens Healthineers
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
139
Number of Tables & Figures
98
Customization Available
Yes, the report can be customized as per your need.
Global Blood Testing Market Report Segments:
The global Blood Testing market is segmented on the basis of:
Types
Glucose, Lipid, BUN, A1C, CRP, Vitamin D, ALT, AST, Thyroid Stimulating Hormone
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinic and Diagnostic Centers, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- Bio-Rad Laboratories
- F. Hoffmann La Roche
- Siemens Healthineers
Highlights of The Blood Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Glucose
- Lipid
- BUN
- A1C
- CRP
- Vitamin D
- ALT
- AST
- Thyroid Stimulating Hormone
- By Application:
- Hospitals
- Clinic and Diagnostic Centers
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Blood Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Blood testing is a medical procedure that involves taking a sample of blood from a person for analysis. Blood tests can be used to determine the presence or absence of certain substances in the blood, to measure levels of specific substances in the blood, or to diagnose conditions such as cancer.
Some of the major companies in the blood testing market are Abbott Laboratories, Bio-Rad Laboratories, F. Hoffmann La Roche, Siemens Healthineers.
The blood testing market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Blood Testing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Blood Testing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Blood Testing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Blood Testing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Blood Testing Market Size & Forecast, 2018-2028
4.5.1 Blood Testing Market Size and Y-o-Y Growth
4.5.2 Blood Testing Market Absolute $ Opportunity
Chapter 5 Global Blood Testing Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Blood Testing Market Size Forecast by Type
5.2.1 Glucose
5.2.2 Lipid
5.2.3 BUN
5.2.4 A1C
5.2.5 CRP
5.2.6 Vitamin D
5.2.7 ALT
5.2.8 AST
5.2.9 Thyroid Stimulating Hormone
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Blood Testing Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Blood Testing Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinic and Diagnostic Centers
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Blood Testing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Blood Testing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Blood Testing Analysis and Forecast
9.1 Introduction
9.2 North America Blood Testing Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Blood Testing Market Size Forecast by Type
9.6.1 Glucose
9.6.2 Lipid
9.6.3 BUN
9.6.4 A1C
9.6.5 CRP
9.6.6 Vitamin D
9.6.7 ALT
9.6.8 AST
9.6.9 Thyroid Stimulating Hormone
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Blood Testing Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinic and Diagnostic Centers
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Blood Testing Analysis and Forecast
10.1 Introduction
10.2 Europe Blood Testing Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Blood Testing Market Size Forecast by Type
10.6.1 Glucose
10.6.2 Lipid
10.6.3 BUN
10.6.4 A1C
10.6.5 CRP
10.6.6 Vitamin D
10.6.7 ALT
10.6.8 AST
10.6.9 Thyroid Stimulating Hormone
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Blood Testing Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinic and Diagnostic Centers
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Blood Testing Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Blood Testing Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Blood Testing Market Size Forecast by Type
11.6.1 Glucose
11.6.2 Lipid
11.6.3 BUN
11.6.4 A1C
11.6.5 CRP
11.6.6 Vitamin D
11.6.7 ALT
11.6.8 AST
11.6.9 Thyroid Stimulating Hormone
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Blood Testing Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinic and Diagnostic Centers
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Blood Testing Analysis and Forecast
12.1 Introduction
12.2 Latin America Blood Testing Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Blood Testing Market Size Forecast by Type
12.6.1 Glucose
12.6.2 Lipid
12.6.3 BUN
12.6.4 A1C
12.6.5 CRP
12.6.6 Vitamin D
12.6.7 ALT
12.6.8 AST
12.6.9 Thyroid Stimulating Hormone
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Blood Testing Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinic and Diagnostic Centers
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Blood Testing Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Blood Testing Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Blood Testing Market Size Forecast by Type
13.6.1 Glucose
13.6.2 Lipid
13.6.3 BUN
13.6.4 A1C
13.6.5 CRP
13.6.6 Vitamin D
13.6.7 ALT
13.6.8 AST
13.6.9 Thyroid Stimulating Hormone
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Blood Testing Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinic and Diagnostic Centers
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Blood Testing Market: Competitive Dashboard
14.2 Global Blood Testing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott Laboratories
14.3.2 Bio-Rad Laboratories
14.3.3 F. Hoffmann La Roche
14.3.4 Siemens Healthineers
